Thank you, Mr. Chair.
Thank you, all, for coming. I have two questions.
Much of what you have said we've heard. I don't want to minimize it, but you're just re-emphasizing what's taking place across the challenges. But there are two things that jumped out at me and the committee members as a whole.
The first question I'm going to direct to you, Mr. Kanters, because you raised the issue about patents. We heard this morning that when your companies develop things, some of the multinationals take these developments to China and get these things made in China. Do you want to elaborate on that? That was just absolutely shocking.
Does anybody want to elaborate on that, someone who knows about it? We heard this from the last bunch of witnesses.